SCHEMBL8290586

SCHEMBL8290586

CC(C)[C@H](NC(=O)N[C@H]1CCCCCCCC[C@@H](C(=O)C(N)=O)NC(=O)[C@@H]2[C@@H]3[C@H](CN2C1=O)C3(C)C)C(=O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8255465 1.00 — —
SCHEMBL16349662 0.94 — —
SCHEMBL13685746 0.92 — —
SCHEMBL13685690 0.90 CTSV (0.35) —
SCHEMBL8291298 0.89 — —
SCHEMBL8248377 0.89 — —
SCHEMBL8291136 0.87 — —
SCHEMBL8290590 0.87 — —
SCHEMBL16349664 0.83 — —
SCHEMBL7857551 0.83 CTSV (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 — — WO disclosed
Send feedback